ArticleHuman vaccines & immunotherapeutics2019

Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice.

Juan Jose de la Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.